Jama Pitman - Net Worth and Insider Trading

Jama Pitman Net Worth

The estimated net worth of Jama Pitman is at least $1 Million dollars as of 2024-11-13. Jama Pitman is the SVP, Chief Development Officer of Deciphera Pharmaceuticals Inc and owns about 50,573 shares of Deciphera Pharmaceuticals Inc (DCPH) stock worth over $1 Million. Details can be seen in Jama Pitman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jama Pitman has not made any transactions after 2024-01-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Jama Pitman

To

Jama Pitman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jama Pitman owns 1 companies in total, including Deciphera Pharmaceuticals Inc (DCPH) .

Click here to see the complete history of Jama Pitman’s form 4 insider trades.

Insider Ownership Summary of Jama Pitman

Ticker Comapny Transaction Date Type of Owner
DCPH Deciphera Pharmaceuticals Inc 2024-01-16 SVP & Regulatory & Quality

Jama Pitman Latest Holdings Summary

Jama Pitman currently owns a total of 1 stock. Jama Pitman owns 50,573 shares of Deciphera Pharmaceuticals Inc (DCPH) as of January 16, 2024, with a value of $1 Million.

Latest Holdings of Jama Pitman

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
DCPH Deciphera Pharmaceuticals Inc 2024-01-16 50,573 25.59 1,294,163

Holding Weightings of Jama Pitman


Jama Pitman Form 4 Trading Tracker

According to the SEC Form 4 filings, Jama Pitman has made a total of 7 transactions in Deciphera Pharmaceuticals Inc (DCPH) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Deciphera Pharmaceuticals Inc is the sale of 1,624 shares on January 16, 2024, which brought Jama Pitman around $23,499.

Insider Trading History of Jama Pitman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jama Pitman Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jama Pitman Ownership Network

Ownership Network List of Jama Pitman

No Data

Ownership Network Relation of Jama Pitman

Insider Network Chart

Jama Pitman Owned Company Details

What does Deciphera Pharmaceuticals Inc do?

Who are the key executives at Deciphera Pharmaceuticals Inc?

Jama Pitman is the SVP & Regulatory & Quality of Deciphera Pharmaceuticals Inc. Other key executives at Deciphera Pharmaceuticals Inc include EVP & Chief Medical Officer Matthew L Sherman , Chief Financial Officer Thomas Patrick Kelly , and Chief Commercial Officer Daniel C. Martin .

Deciphera Pharmaceuticals Inc (DCPH) Insider Trades Summary

Over the past 18 months, Jama Pitman made 4 insider transaction in Deciphera Pharmaceuticals Inc (DCPH) with a net sale of 5,931. Other recent insider transactions involving Deciphera Pharmaceuticals Inc (DCPH) include a net sale of 23,797 shares made by Daniel C. Martin , a net sale of 12,184 shares made by Matthew L Sherman , and a net sale of 9,198 shares made by Thomas Patrick Kelly .

In summary, during the past 3 months, insiders sold 0 shares of Deciphera Pharmaceuticals Inc (DCPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 105,002 shares of Deciphera Pharmaceuticals Inc (DCPH) were sold and 10,000 shares were bought by its insiders, resulting in a net sale of 95,002 shares.

Deciphera Pharmaceuticals Inc (DCPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Deciphera Pharmaceuticals Inc Insider Transactions

No Available Data

Jama Pitman Mailing Address

Above is the net worth, insider trading, and ownership report for Jama Pitman. You might contact Jama Pitman via mailing address: C/o Deciphera Pharmaceuticals, Inc., 200 Smith Street, Waltham Ma 02451.